Discover comprehensive details about Dantrolene, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Study design: Single-subject case (a quadriplegic female, 56 years). Objectives: To describe a new case of eosinophilic pleural effusion induced by dantrolene chronic administration. Setting: Physical ...

A substantial number of patients receive care in ambulatory surgical centers. Experts say storing the drug dantrolene at ambulatory surgical centers will save lives and is very cost effective.

The US Food and Drug Administration (FDA) has approved an injectable form of dantrolene sodium (Ryanodex, Eagle Pharmaceuticals) for rapid treatment of malignant hyperthermia (MH), along with the ...

Review the side-effects of Dantrolene as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”) today announced that Eagle and the University of Pennsylvania (“Penn”) have agreed on terms of a new ...

Dantrolene sodium 20mg; per vial; lyophilized pwd for IV inj after reconstitution; contains mannitol. In isolated nerve-muscle preparation, dantrolene sodium has been shown to produce relaxation by ...

Dantrolene sodium is a medication that inhibits binding of ryanodine to the ryanodine receptor type 1 on the sarcoplasmic reticulum membrane in skeletal muscle, inhibiting calcium release. This leads ...

Predictive value of neutrophil-to-lymphocyte ratio on pathological complete response in triple negative breast cancer. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This ...

Malignant hyperthermia is a condition that’s often triggered by certain anesthesia drugs and can be life threatening. The condition impacts an estimated 1 in every 100,000 adult surgeries and 1 in ...

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”) announced today a new research agreement with NorthShore University HealthSystem in Evanston, IL, focused on ...